PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.\', \'International Collaboration Unit, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.\', \'National Virus Reference Laboratory (NVRL), University College Dublin, Dublin, Ireland.\', \'Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland on behalf of the All Ireland Infectious Diseases (AIID) Cohort.\', \'Teagasc Food Research Centre, Moorepark, Fermoy, Ireland on behalf of the Irish Coronavirus Sequencing Consortium (ICSC).\', \'Health Service Executive - Health Protection Surveillance Centre (HPSC), Dublin, Ireland.\', \'Health Directorate, Findel, Luxembourg.\', \'National Health Laboratory, Dudelange, Luxembourg.\', \'Istituto Superiore di Sanità, Rome, Italy.\', \'Directorate of Analysis and Information, Directorate-General of Health, Lisbon, Portugal.\', \'Bioinformatics Unit, Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.\', \'Health Board, Tallinn, Estonia.\', \'Finnish Institute for Health and Welfare (THL), Department of Health Security, Helsinki, Finland.\', \'The COVID study groups are listed at the end of this article under Acknowledgements.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2021.26.16.2100348
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 33890566
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all